Hepatocellular Carcinoma Prognosis | Medical Algorithm

Evaluation

Are you evaluating a patient with hepatocellular carcinoma?

Yes

MELD score

Has the patient been treated for the hepatocellular carcinoma?

Yes

Is the serum AFP elevated?

Yes

Serum albumin

g/dL

Is the serum creatinine elevated?

Yes

Tumor stage

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of factors associated with an extremely poor survival

Percent of patients with this MELD score living less than 1 month if the serum albumin is 3 g/dL

Percent of patients with this MELD score living less than 1 month if the serum albumin is 2.5 g/dL

Percent of patients with this MELD score living less than 1 month if the serum albumin is 2 g/dL

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Laboratory Tests
- Advanced Cancer Vitamin B12 to C-Reactive Protein (CRP) Ratio
Criteria For Diagnosis
- San Diego Severity Index (SDSI) for Patients with Terminal Cancer
- Models for Predicting Survival in Patient with Advanced Cancer
Severity, Prognosis, Stage
Complications
- San Diego Severity Index (SDSI) for Patients with Terminal Cancer
- Models for Predicting Survival in Patient with Advanced Cancer

Therapy

Selection
- Prognostic Models for Phase I Clinical Trials
Interventional Radiology
- Survival Model for Patient Undergoing Radiotherapy for Metastatic Spinal Cord Compression

Monitoring

Response To Therapy
- Survival Model for Patient Undergoing Radiotherapy for Metastatic Spinal Cord Compression
- Prognostic Models for Phase I Clinical Trials
Disease Progression
- Predictors for Early Death of Older Adult Starting Cancer Chemotherapy

Patient Concerns

End-of-life, Palliative Care

Specialty

Hematology Oncology
Surgery, general

Objective

severity
prognosis
stage

ICD-10

C22 - Malignant neoplasm of liver and intrahepatic bile ducts

Hepatocellular Carcinoma Predictive Factors for Survival

Purpose: To identify a patient with hepatocellular carcinoma who may have an extremely poor survival (< 1 month) based on the study of Wray et al.